CANSWERIST® explores immunotherapy



The DX came in 2006.  That is the abbreviation for diagnosis and the condition was an abbreviation known as MCL (mantle cell lymphoma).

While I did not start my cancer diagnosis and treatment at City of Hope, that is the facility to which I give the most credit for my continuous remission since 2010.

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission. @STORY

Daneng Li, M.D., is treating patients with advanced liver (hepatocellular) cancer, while Joseph Chao, M.D., is treating patients with advanced stomach and esophageal cancer (gastric and gastroesophageal junction adenocarcinoma). Both City of Hope medical oncologists are offering hope to patients who have tried chemotherapy and other treatments for their cancer without experiencing prolonged remission.

Australian lobster fisherman David Thompson traveled 9,000 miles for treatment at City of Hope after being diagnosed with Stage 4 oropharyngeal cancer. Given just six weeks to live, he is thriving more than a year after participating in an immunotherapy clinical trial. @STORY

CANSWERIST® Flipboard by socialcurrentsee.com®▶ Immune System, Science, Comments by MCL survivor since 2006 following an SCT (2007), in continuous remission (CR) since 2010▶ Maintenance involves quarterly IVIGs to boost immune system▶ canswerist.com®

City of Hope is one of only 49 comprehensive cancer centers in the nation, the highest designation possible from the National Cancer Institute.

City of Hope
READ
READ